Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This study was performed to determine whether calcitriol provides a therapeutic advantage to
alfacalcidol for treatment of secondary hyperparathyroidism in ESRD patients.